Illumina Radiopharmaceuticals
New York, US · Founded 2019 · Delaware LLC
Founders & leadership
DB
David BattlemanNamed on SEC filing
SJ
Scott J. KormanNamed on SEC filing
DT
David TurnerNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$250K disclosed across 1 round · 2019
▶$250KraisedJun 2019 · 1 investors · PharmaceuticalsRule 506(b)
▶$250KraisedJun 2019 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- David BattlemanExecutive Officer
- Scott J. KormanExecutive Officer
- David TurnerExecutive Officer
- Offering amount
- $9M
- Amount sold
- $250K
- Minimum investment
- $25K
- Proceeds to insiders
- $180K
- Placement agents
- Pickwick Capital Partners, LLC
- First sale
- May 2019
- Incorporated
- Limited Liability Company, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Illumina Radiopharmaceuticals raised?
- Illumina Radiopharmaceuticals has disclosed $250K raised across 1 round.
- Where is Illumina Radiopharmaceuticals headquartered?
- Illumina Radiopharmaceuticals is headquartered in New York, US.